CVS Health · 11 hours ago
Analyst, Financial Operations
CVS Health is a company focused on shaping a more connected and compassionate health experience. As a Rebate Claims Analyst, you will manage the invoicing of drug manufacturer rebates, validate claims, and collaborate with internal and external partners to ensure timely processing of claims.
Health CareMedicalPharmaceuticalRetailSales
Responsibilities
Creating and running SQL queries to identify claim anomalies and perform ad hoc analysis
Performing monthly claims validation procedures in preparation for rebate invoicing to drug manufacturers
Researching plan designs in the adjudication system
Verifying client plan design tiers, reviewing and analyzing formulary assignments
Working within the rebate claim system to update claim information
Working with implementation and account teams to on-board new Rebate Only clients in the rebate system
Qualification
Required
Experience analyzing data with SQL in a professional or academic setting
Experience with Microsoft Excel
Bachelor's degree preferred or equivalent experience
Preferred
Knowledge of pharmaceutical products/pharmaceutical industry
Strong written and oral communication skills
Benefits
Affordable medical plan options
401(k) plan (including matching company contributions)
Employee stock purchase plan
No-cost programs for all colleagues including wellness screenings
Tobacco cessation and weight management programs
Confidential counseling and financial coaching
Benefit solutions that address the different needs and preferences of our colleagues including paid time off
Flexible work schedules
Family leave
Dependent care resources
Colleague assistance programs
Tuition assistance
Retiree medical access and many other benefits depending on eligibility
Company
CVS Health
CVS Health is a health solutions company that provides an integrated healthcare services to its members.
Funding
Current Stage
Public CompanyTotal Funding
$4BKey Investors
Michigan Economic Development CorporationStarboard Value
2025-08-15Post Ipo Debt· $4B
2025-07-17Grant· $1.5M
2019-11-25Post Ipo Equity
Leadership Team
Recent News
The Motley Fool
2026-01-22
bloomberglaw.com
2026-01-22
Maryland Daily Record
2026-01-19
Company data provided by crunchbase